USD 0.0005  0.00  0.00%   

The current indifference towards the small price fluctuations of ARYX THERAPEUTICS INC could raise concerns from investors as the firm is trading at a share price of 5.0E-4 on slow start in volume. The company executives did not add any value to ARYX THERAPEUTICS investors in September. However, most investors can still diversify their portfolios with ARYX THERAPEUTICS INC to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Please continue to Trending Equities.
The ARYX THERAPEUTICS stock analysis report makes it easy to digest most publicly released information about ARYX THERAPEUTICS and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ARYX THERAPEUTICS Stock analysis module also helps to analyze the ARYX THERAPEUTICS price relationship with some important fundamental indicators such as market cap and management efficiency.

ARYX THERAPEUTICS Stock Analysis Notes

The company recorded a loss per share of 0.59. ARYX THERAPEUTICS INC had not issued any dividends in recent years. ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. Aryx Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. For more info on ARYX THERAPEUTICS INC please contact Paul Goddard at 510 585 2200 or go to


Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ARYX THERAPEUTICS's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ARYX THERAPEUTICS INC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ARYX THERAPEUTICS is not currently marked as verified by its exchange. Report It!

ARYX THERAPEUTICS Market Capitalization

The company currently falls under 'Nano-Cap' category with current market capitalization of 51.65 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ARYX THERAPEUTICS's market, we take the total number of its shares issued and multiply it by ARYX THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (74.86) % which means that it has lost $74.86 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (13243.0) %, meaning that it created substantial loss on money invested by shareholders. ARYX THERAPEUTICS management efficiency ratios could be used to measure how well aryx therapeutics inc manages its routine affairs as well as how well it operates its assets and liabilities.

ARYX THERAPEUTICS INC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ARYX THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on ARYX THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ARYX THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ARYX THERAPEUTICS Technical and Predictive Indicators

About ARYX THERAPEUTICS Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ARYX THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ARYX THERAPEUTICS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as ARYX THERAPEUTICS. By using and applying ARYX THERAPEUTICS Stock analysis, traders can create a robust methodology for identifying ARYX THERAPEUTICS entry and exit points for their positions.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. Aryx Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ARYX THERAPEUTICS to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Headlines Timeline Now


Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module
Please continue to Trending Equities. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Tools for ARYX THERAPEUTICS Stock

When running ARYX THERAPEUTICS INC price analysis, check to measure ARYX THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARYX THERAPEUTICS is operating at the current time. Most of ARYX THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ARYX THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARYX THERAPEUTICS's price. Additionally, you may evaluate how the addition of ARYX THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEO Directory
Screen CEOs from public companies around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format